{"doc_id": "PMC-1310901-03-MATERIALS_AND_METHODS-02.txt", "sent_id": "", "tokens": ["Cell", "culture", "and", "stimulation"], "sentence": "Cell culture and stimulation", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-03-MATERIALS_AND_METHODS-02.txt", "sent_id": "", "tokens": ["All", "cell", "lines", "were", "maintained", "at", "5", "%", "CO2", "in", "RPMI", "1640", "medium", "with", "1", "%", "glutamine", "(", "Gibco", "/", "BRL", "Eggenstein", ",", "Germany", ")", "supplemented", "with", "10", "%", "fetal", "calf", "serum", "(", "Gibco", "/", "BRL", ")", ",", "1", "%", "penicillin", "/", "streptomycin", "(", "Biochrom", ",", "Berlin", ",", "Germany", ")", "."], "sentence": "All cell lines were maintained at 5 % CO2 in RPMI 1640 medium with 1 % glutamine ( Gibco / BRL Eggenstein , Germany ) supplemented with 10 % fetal calf serum ( Gibco / BRL ) , 1 % penicillin / streptomycin ( Biochrom , Berlin , Germany ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-03-MATERIALS_AND_METHODS-02.txt", "sent_id": "", "tokens": ["When", "indicated", ",", "cells", "were", "treated", "with", "5-aza-2-deoxycytidine", "(", "AzadC", ")", "or", "5-azacytidine", "(", "AzaC", ")", "(", "Sigma", ",", "Taufkirchen", ",", "Germany", ")", "for", "different", "time", "periods", "."], "sentence": "When indicated , cells were treated with 5-aza-2-deoxycytidine ( AzadC ) or 5-azacytidine ( AzaC ) ( Sigma , Taufkirchen , Germany ) for different time periods .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-03-MATERIALS_AND_METHODS-02.txt", "sent_id": "", "tokens": ["Owing", "to", "their", "chemical", "instability", "fresh", "substances", "were", "re-added", "every", "24", "h", "."], "sentence": "Owing to their chemical instability fresh substances were re-added every 24 h .", "event_mentions": [], "entity_mentions": []}
